宝藤生物,精准医学领导者

微信
Medical Big Data

In recent years, with the rapid development of genomics, proteomics, metabonomics and other multi-group technology, people have researched on gene, protein, cells and other aspects of exploration, study the occurrence of disease, development mechanism for the diagnosis and treatment of diseases ,found new ideas and provided new ways. The concept of disease diagnosis &treatment has also experienced from the medicine evidence experience to the development of precision medicine. Molecular diagnostics is currently the world's largest investment in biomedical field &the fastest growing industry. Precision medicine is an advanced innovation model that integrates expert resources, medical resources and industrial capital resources to achieve collaborative innovation and industrialization of biological high-tech innovation. It is an important propeller to promote the clinical application and practice of high-tech achievements. It is aligned to China’s 13rd “ Five years plan”,( innovation-driven, transformation & development) "strategic requirements of the important practice. To achieve the domestic large-scale top level three hospitals and Shanghai Zhangjiang national bio-pharmaceutical industry base complementary advantages and sharing of resources ,to jointly promote the transformation of biomedical innovation and application of the industrialization process, Shanghai Biotecan and the top level three hospitals carry out work together strategic cooperation & then jointly build " Medical data center "(hereinafter referred to as the center).

First, the Center Positioning

The center is building with the world's leading medical transformation research &development , business solution center of molecular diagnostics and individualized medicine, medical big data, cloud computing analysis.

Second, Construction Platform

1)Clinical molecular diagnostic center aligns with international and domestic Standard Criteria: We will invest in world-class hardware platform, innovative technology with proprietary intellectual property rights, big database and large systems of hardware and software, provide a molecular diagnostic system solution required by hospital clinical diagnosis and research. 2)Biotecan Jointly establish a high-end health management center of new generation sequencing (NGS) with the hospital in accordance with the international first-class Standard Criteria. Customized /personalized health management solution according to the characteristics of the patient's genre, establish standardized health data collection and follow-up system to promote the construction of hospital medicine data center.3) Establish a medical cloud computing center, including large-scale disease clinical database, genome reference database, mass data processing mining &medical report generation automation software system and mobile customer service, then to provide supportive research platform、genomics, proteomics, metabonomics and other clinical data .

Third, the Expected Achievement

1. Support function: for the two sides to transform the medical research to provide a common technical support platform, to promote integrated innovation;
2. Agglomeration function: Through the construction of large international standard technology network and medical data cloud computing center to attract outstanding talents at home and abroad, pharmaceutical enterprises, investment funds, etc., to play the advantages of resource agglomeration effect, then promote the development of medical reform.
3. Service Function: Provide precision medical services to customs and medical institutions. After the completion of the medical big data center, it will provide a systematic clinical diagnosis of clinical services, to enhance the hospital's brand and medical service quality, meanwhile the industrialization Union of hospital-enterprise cooperation will be formed. Promote the most advanced technology, and create a win-win development pattern in China. As an important node of the national medical big data network, hospital can share the medical data, and carry out the medicine transformation, to establish a detailed clinical information on the Chinese population disease-related gene database, to achieve a great-leap-forward and sustainable development on hospital research. Medical big data will play a significant part, the largest medical big data center in China build by Biotecan will be adhering to starting point and final goal of "Data is assets, data is service.", relying on the national network of Biotecan’s large medical big data network, integrate of Biotecan unique data resources and industrial resources, dig and exploit medical data deeply , through the combination of model innovation µ innovation, to achieve conversion from data value to data assets, to data capital, stimulate traditional medicine Industrial structure escalation and push forward it growth


  • Contact Us
  • Shanghai Biotecan Pharmaceuticals Co. , Ltd.
  • Telephone:+86-21-50277725
  • Address

    First Shanghai Centre, 180 Zhangheng Rd., Pudong New District, Shanghai, China

Copyright © 2015-2018 Shanghai Biotecan Pharmaceuticals Co.,Ltd All Rights Reserved 沪ICP备09055310号-1 沪公网安备 31011502003232号